If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Tuberculosis is finally being addressed, giving hope to TB patients especially those with multidrug-resistant TB (MDR-TB). Although we have medicines available, there is still research to be done to grant appropriate treatment to those in need.